RESEARCH ARTICLE Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia Julio Cesar Rendon1, Fabian Cortes-Mancera2, Juan Carlos Restrepo-Gutierrez1,3, Sergio Hoyos1,3, Maria-Cristina Navas1* 1 Grupo de Gastrohepatologia, Facultad de Medicina, Universidad de Antioquia, UdeA, Medellin, Colombia, 2 Grupo de InvestigacioÂn e Innovacion BiomeÂdica GI2B, Facultad de Ciencias Exactas y Aplicadas, Instituto a1111111111 Tecnologico Metropolitano (ITM), Medellin, Colombia, 3 Unidad de Hepatologia y Trasplante Hepatico, a1111111111 Hospital Pablo Tobon Uribe, Medellin, Colombia a1111111111 a1111111111 *
[email protected] a1111111111 Abstract OPEN ACCESS Background Citation: Rendon JC, Cortes-Mancera F, Restrepo- Hepatitis B virus (HBV) occult infection (OBI) is a risk factor to be taken into account in trans- Gutierrez JC, Hoyos S, Navas M-C (2017) fusion, hemodialysis and organ transplantation. The aim of this study was to identify and Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver characterize at the molecular level OBI cases in patients with end-stage liver disease. disease in Colombia. PLoS ONE 12(7): e0180447. https://doi.org/10.1371/journal.pone.0180447 Methods Editor: Isabelle Chemin, Centre de Recherche en Sixty-six liver samples were obtained from patients with diagnosis of end-stage liver Cancerologie de Lyon, FRANCE disease submitted to liver transplantation in Medellin (North West, Colombia). Samples Received: February 1, 2017 obtained from patients who were negative for the surface antigen of HBV (n = 50) were Accepted: June 15, 2017 tested for viral DNA detection by nested PCR for ORFs S, C, and X and confirmed by South- Published: July 7, 2017 ern-Blot.